您目前的位置:院首页>首页 > 副教授

谢英

副教授 硕士生导师

 

谢英 博士, 副教授, 硕士生导师

药剂系党支部书记、副主任

Associate Prof. Ying Xie

Tel: (+8610) 82805351 (Office)

Email: bmuxieying@bjmu.edu.cn

谢英,1996年毕业于北京师范大学化学系物理化学专业,获理学硕士学位,2005年获得北京大学药剂学博士学位。现兼任中国药学会药剂专业委员会秘书,中国颗粒学会药物制剂与粒子设计专委会委员,第五批医疗器械技术审评(CMDE)外聘专家,黑龙江省科技厅项目、河北省科技厅项目、北京自然科学基金,教育部学位论文、Science Advance等期刊评审专家。

北京大学药学院《物理化学》和《物理化学实验》课程负责人,作为副主编及参编药学相关专著及教材17部。19931996年从事生物抗氧化过程酶催化机理的研究,参加两项国家自然科学基金资助项目;1996年以来从事药剂学研究,为多项新药制剂提供技术服务,负责北大方正创新药物研究基金1项,主持或作为共同申请人负责国家自然科学基金资助项目3项,作为主要研究人员参加国家重大科学研究计划(973)《纳米技术改善难溶性药物功效的应用基础》、重大新药创制、新制剂与新释药系统技术平台的研究工作。发表论文50余篇,申请/授权专利12/5项。获教育部科技进步二等奖(2004年),DOVE PRESS首届中文摘要视频大赛奖(2015年)等。

研究方向

新型药物递送系统与生物药剂学

主要研究内容

脑靶向给药系统、微针透皮贴片等

代表论文

(1) Ren Y#, Li P#, Xie Y#, Xu J, Luo Q, Chen M, Liu R, Feng H, Chen Y, Liu Y, Bao C, Duan J, Li J*, Lu W*. Dual-responsive nanoparticles for enhanced drug delivery in breast Cancer chemotherapy. J Control Release. 2025, 377:146–161. doi: 10.1016/j.jconrel.2024.11.026. Epub ahead of print. PMID: 39549730. [IF 10.5]

(2) Chen S#, Wang J#, Sun L, Xia F, Li W, Yuan L, Liu C, Li P, Bao C, Wang M, Wang G, Li J, Xie Y*, Lu W. A quick paster type of soluble nanoparticle microneedle patch for the treatment of obesity. Biomaterials. 2024 Jun 24; 311:122687. doi: 10.1016/j.biomaterials.2024.122687. Epub ahead of print. PMID: 38941683. [IF 12.8]

(3) Li P#, Xie Y#, Wang J#, Bao C, Duan J, Liu Y, Luo Q, Xu J, Ren Y, Jiang M, Li J, Guo H, Zhao H, Wang G, Liang Y*, Lu W*. Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy. Bioact Mater. 2024 Jan 13; 34:466-481. doi: 10.1016/j.bioactmat.2024.01.008. PMID: 38292412; PMCID: PMC10825617. [IF 18.9]

(4) Chen YL#, Bao CJ#, Duan JL#, Xie Y*, Lu WL*. Overcoming biological barriers by virus-like drug particles for drug delivery. Adv Drug Deliv Rev. 2023 Dec;203:115134. doi: 10.1016/j.addr.2023.115134. Epub 2023 Nov 4. PMID: 37926218. [IF 16.1]

(5) Bao CJ#, Duan JL#, Xie Y#, Feng XP, Cui W, Chen SY, Li PS, Liu YX, Wang JL, Wang GL, Lu WL*. Bioorthogonal Engineered Virus-Like Nanoparticles for Efficient Gene Therapy. Nanomicro Lett. 2023 Aug 12;15(1):197. doi: 10.1007/s40820-023-01153-y. PMID: 37572220; PMCID: PMC10423197. [IF 26.6]

(6) Chunjie Bao#, Jialun Duan#, Ying Xie#, Yixuan Liu, Peishan Li, Jianwei Li, Huihui Zhao, Haitao Guo, Yanchen Men, Yuxin Ren, Jiarui Xu, Guiling Wang, and Wanliang Lu*. A novel oncogenic enhancer of estrogen receptor-positive breast cancer. Molecular Therapy: Nucleic Acids. 2022, 29(9): 836-851. [IF 10.183]

(7) Liu Rui#, Xie Ying#, Xu Jiarui, Luo Qian, Ren Yuxin, Chen Ming, Duan Jialun, Bao Chunjie, Liu Yixuan, Li Peishan, Li Jianwei, Wang Guiling, Lu Wanliang*. Engineered stem cell biomimetic liposomes carrying levamisole for macrophage immunity reconstruction in leukemia therapy, Chemical Engineering Journal, 2022, 447, 137582. [IF 16.744]

(8) Jialun Duan#, Chunjie Bao#, Ying Xie#, Haitao Guo, Yixuan Liu, Jianwei Li, Rui Liu, Peishan Li, Jing Bai, Yan Yan, Limin Mu, Xueqi Li, Guiling Wang, Wanliang Lu*, Targeted core-shell nanoparticles for precise CTCF gene insert in treatment of metastatic breast cancer, Bioactive Materials, 2021,7;11:1-14. [IF 16.874]

(9) Li Xueqi#, Li Jianwei#, Xu Jiarui, Chen Kun, Zhang Zhan, Duan Jialun, Luo Qian, Du Yafei, Chen Songyue, Xie Ying*, Lu Wanliang*. Nanostructure of Functional Larotaxel Liposomes Decorated with Guanine-Rich Quadruplex Nucleotide-Lipid Derivative for Treatment of Resistant Breast Cancer. Small. 2021 Jan 31:e2007391. doi: 10.1002/smll.202007391. [IF 15.153]

(10)  Yu Yu-Ping , Wang Qi , Liu Ying-Chun*, Xie Ying*Molecular basis for the targeted binding of RGD-containing peptide to integrin aVb3Biomaterials , 2014, 35(5):1667-1675.